SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-015012
Filing Date
2023-05-01
Accepted
2023-05-01 17:00:40
Documents
125
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form20-f.htm   iXBRL 20-F 3875373
2 form20-f_001.jpg GRAPHIC 109825
3 ex12-1.htm EX-12.1 13969
4 ex12-2.htm EX-12.2 14175
5 ex13-1.htm EX-13.1 6542
6 ex13-2.htm EX-13.2 6572
  Complete submission text file 0001493152-23-015012.txt   15200663

Data Files

Seq Description Document Type Size
7 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT incr-20221231.xsd EX-101.SCH 101734
8 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT incr-20221231_cal.xml EX-101.CAL 108771
9 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT incr-20221231_def.xml EX-101.DEF 357887
10 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT incr-20221231_lab.xml EX-101.LAB 622355
11 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT incr-20221231_pre.xml EX-101.PRE 513248
119 EXTRACTED XBRL INSTANCE DOCUMENT form20-f_htm.xml XML 3264051
Mailing Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670
Business Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670 972774605012
Intercure Ltd. (Filer) CIK: 0001857030 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-40614 | Film No.: 23874772
SIC: 2834 Pharmaceutical Preparations